Description
This model improves human myeloid cell development in hu-HSC (CD34⁺ HSCs treatment mice) mice by overexpressing hIL3/hCSF2.
Applications
Human-specific infectious diseases; Antibody-based immune therapy; Human-specific vaccine development; Cell-based adoptiive immunity
Strain Name
NSG (E-hIL3/hCSF2)
Datasheet